- - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

About the Ed Book | ASCO Educational Book

ISSN Print:

ISSN Online:

主页: http://ascopubs.org/edbk/about.html

分享:

State-of-the-Art Management of Germ Cell Tumors

Darren R. Feldman

Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices

Edward S. Kim,Jennifer L. Ersek,Lora J. Black,Michael A. Thompson

Cardiac Toxicities in the Era of Precision Medicine: Underlying Risk Factors, Targeted Therapies, and Cardiac Biomarkers

Anne H. Blaes,Javid Moslehi,Paaladinesh Thavendiranathan

New Era in the Management of Melanoma Brain Metastases

Caroline Robert,Celine Boutros,David Kok,Grant McArthur,Hussein A. Tawbi

Major Changes in Head and Neck Staging for 2018

Brian O’Sullivan,Snehal Patel,William Lydiatt

Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment

Andrew W. Hahn,Celestia S. Higano,Charles J. Ryan,Mary-Ellen Taplin,Neeraj Agarwal

Combination Immunotherapy Development in Melanoma

Alex,Jennifer Wargo,Marka Crittenden,er M. M. Eggermont

“How Much Time Do I Have?”: Communicating Prognosis in the Era of Exceptional Responders

Jennifer S. Temel,Paul R. Helft,Thomas W. LeBlanc

Cognitive Changes in Cancer Survivors

Jeffrey S. Wefel,Kevin R. Krull,Michelle Janelsins,Sara J. Hardy

Caring for Colleagues and Loved Ones With Cancer

John W. Cook,Julia L. Close,Melissa Dillmon,Ranjana Srivastava,Rebecca D. Pentz,Stephanie L. Graff

Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy

Alex,Olivier Michielin,Ragini R. Kudchadkar,er C. J. van Akkooi

Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice

Evanthia Galanis,Farhad Nassiri,Gelareh Zadeh,Romina Nejad,S,Shannon Coy,ro Santagata

Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions

Anthony L. Zietman,Gary D. Steinberg,Jeanny B. Aragon-Ching,Ryan P. Werntz

Moving From Mutation to Actionability

Amit M. Oza,Ilaria Colombo,Katherine C. Kurnit,Shannon N. Westin

So Much Data, So Little Knowledge: Using Formal Logic to Aggregate Data and Interpret Information

J. Russell Hoverman

Complexity of Delivering Precision Medicine: Opportunities and Challenges

Amy E. McKee,Andrew A. Davis,Victoria M. Villaflor,Warren A. Kibbe

Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer

Heather Cheng,Jacquelyn Powers,Kerry Schaffer,Oliver Sartor

Risk Stratification and Targets in Multiple Myeloma: From Genomics to the Bedside

Aurore Perrot,Hervé Avet-Loiseau,Jill Corre

Patterns of Response and Progression to Immunotherapy

Amara N,Christophe Le Tourneau,Edith Borcoman,Georgina Long,Sanjay Goel,ikolla

The Winds of Change: Emerging Therapeutics in Prostate Cancer

Ariel E. Marciscano,Carmel J. Pezaro,Ravi A. Madan

Molecular Subtypes and the Evolution of Treatment Decisions in Metastatic Colorectal Cancer

Josep Tabernero,Ramon Salazar,Rodrigo Dienstmann

Emerging Strategies in Systemic Therapy for the Treatment of Melanoma

Keith Flaherty,Paolo A. Ascierto,Stephanie Goff

Liquid Biopsy to Identify Actionable Genomic Alterations

Misako Nagasaka,Sai-Hong Ignatius Ou,Viola W. Zhu

Communicating the Financial Burden of Treatment With Patients

Ellen Miller Sonet,Gery P. Guy Jr.,Ryan D. Nipp

Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began

Jane Lowe Meisel,Lisa Carey,Michael Gnant,Vyshak Alva Venur

Precision Medicine for Primary Central Nervous System Tumors: Are We There Yet?

Franziska Maria Ippen,Howard Colman,Martin J. van den Bent,Priscilla Kaliopi Brastianos

Biology and Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors

Jonathan Strosberg,Nicola Fazio,Nitya Raj

Challenging Cases: Management of Immune-Related Toxicity

Jeffrey S. Weber

Incorporating Genomics Into the Care of Patients With Advanced Breast Cancer

Jeremy Kratz,Lajos Pusztai,Mark Burkard,Philippe L. Bedard,Tess O’Meara,Zachary Veitch

Art and Challenges of Precision Medicine: Interpreting and Integrating Genomic Data Into Clinical Practice

James L. Chen,Somasundaram Subramaniam,Subha Madhavan,Thomas D. Brown

No Decision Is Final: Career Planning and Career Transitions

Brian Boulmay,Marcelo Blaya,Maria Catherine Pietanza,Tatiana Prowell

Incorporating Biology Into Breast Cancer Staging: American Joint Committee on Cancer, Eighth Edition, Revisions and Beyond

Daphne L. Lichtensztajn,Elizabeth A. Mittendorf,John M. S. Bartlett,Sarat Ch,arlapaty

Supporting Caregivers of Patients With Cancer: A Summary of Technology-Mediated Interventions and Future Directions

Ji Youn Shin,Robert B. Noll,Sung Won Choi,Tammy I. Kang

Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing

Aaron S. Mansfield,Ben Ho Park,Michael P. Mullane

Multidisciplinary Management of Oligometastatic Soft Tissue Sarcoma

David G. Kirsch,David S. Demos,Jared D. Christensen,Juneko E. Grilley-Olson,Nicholas P. Webber

Tumor-Agnostic Drug Development

Alex,Dazhi Liu,Michael Offin,er Drilon

Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction

Cynthia A. Thomson,Gil E. Harmon,Jeffrey E. Gershenwald,Noelle K. LoConte,Ruth Rechis,Tracy E. Crane

Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia

Aline Moignet,Thierry Lamy

Tumor Response Assessment for Precision Cancer Therapy: Response Evaluation Criteria in Solid Tumors and Beyond

Mizuki Nishino

Cancer of Unknown Primary Site: New Treatment Paradigms in the Era of Precision Medicine

F. Anthony Greco,John D. Hainsworth

National Cancer Institute Programmatic Collaboration for Investigational Radiopharmaceuticals

Charles A. Kunos,Jacek Capala

Filling the Gap: Creating an Outpatient Palliative Care Program in Your Institution

Esme Finlay,Mary K. Buss,Michael W. Rabow

The Epigenetic Landscape in the Treatment of Gynecologic Malignancies

Ramez N. Esk,er

Ultimate Precision: Targeting Cancer but Not Normal Self-replication

David Schrump,Vamsidhar Velcheti,Yogen Saunthararajah

The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors

Christopher DeRenzo,Giedre Krenciute,Stephen Gottschalk

Is There a Precise Adjuvant Therapy for Esophagogastric Carcinoma?

Elizabeth Cartwright,Florence K. Keane,Ian Chau,Peter C. Enzinger,Theodore Hong

Practical Considerations for Antibodies in Myeloma

Faith E. Davies,Jacob P. Laubach,Joseph Mikhael,Niels van de Donk

Predicting and Preventing Anthracycline-Related Cardiotoxicity

Saro Armenian,Smita Bhatia

Progress Through Collaboration: An ASCO and U.S. Food and Drug Administration Workshop to Improve the Evidence Base for Treating Older Adults With Cancer

Arti Hurria,Harpreet Singh,Heidi D. Klepin

CAR T Cells and Other Cellular Therapies for Multiple Myeloma: 2018 Update

Adam D. Cohen

©2008-2017 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705